How can I find business partners and be in the know on industry intelligence?

    SOCMA’s commercial network helps you find the right connections to develop partnerships with contract manufacturers and customers. We are your bridge to finding suppliers and customers through our lead sheet services, and we are your source of intelligence for end-market insights and product applications. Our ChemSectors network provides the industry intelligence to make key business growth decisions.

    grow your business

    What resources will help me strengthen my operations, train my employees and improve safety?

    Our compliance and stewardship programs promote and guide the implementation of safe, sustainable and environmentally responsible operations across the supply chain.

    discover your resources

    Where can I get intel on the latest regulations and policy specifically impacting specialties?

    We are a powerful industry advocate. Our regulatory and legislative programs ensure you are always at the forefront of any issues or policies that may impact the way you do specialty chemistry.

    find policy solutions

    IN THE NEWS

    September 23, 2020

    SOCMA Adds Another Five Members to its Ranks

    The Society of Chemical Manufacturers & Affiliates (SOCMA) is pleased to announce the addition of five more companies to the association, expanding the total number of new members to 16 in the first three quarters of 2020. SOCMA’s Board of Governors last week approved chemical manufacturer Sofix and service providers Anchin, New York Center for Innovation, POWER Engineers and Rockwell Automation.
    Read more
    September 16, 2020

    Humanigen and Lonza Announce Collaboration to Expand Manufacturing of Humanigen’s COVID-19 Therapeutic Candidate Lenzilumab

    Humanigen, a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper response called ‘cytokine storm,’ and Lonza today announced a strategic collaboration to expand the manufacturing capacity for lenzilumab, currently in Phase 3 clinical trials for COVID-19, in advance of potential Emergency Use Authorization in 2020 and subsequent commercialization.
    Read more

    UPCOMING EVENTS